keyword
MENU ▼
Read by QxMD icon Read
search

ginkgo biloba in PAD

keyword
https://www.readbyqxmd.com/read/18628657/effect-of-ginkgo-biloba-egb-761-on-treadmill-walking-time-among-adults-with-peripheral-artery-disease-a-randomized-clinical-trial
#1
RANDOMIZED CONTROLLED TRIAL
Christopher D Gardner, Ruth E Taylor-Piliae, Alexandre Kiazand, Joel Nicholus, Alison J Rigby, John W Farquhar
PURPOSE: Medical therapies for treatment of peripheral artery disease (PAD) are limited. Ginkgo biloba has been reported to increase maximal and pain-free walking distance among patients with PAD; however, the evidence is inconsistent. The objective of this study was to compare the effects of 300 mg/d of Ginkgo biloba (EGb 761) versus placebo on treadmill walking time and related cardiovascular measures among patients with PAD. METHODS: A double-blind, placebo-controlled, parallel design trial with a 4-month duration was used...
July 2008: Journal of Cardiopulmonary Rehabilitation and Prevention
https://www.readbyqxmd.com/read/17982321/effect-of-ginkgo-biloba-egb-761-and-aspirin-on-platelet-aggregation-and-platelet-function-analysis-among-older-adults-at-risk-of-cardiovascular-disease-a-randomized-clinical-trial
#2
RANDOMIZED CONTROLLED TRIAL
Christopher D Gardner, James L Zehnder, Alison J Rigby, Joel R Nicholus, John W Farquhar
Several case reports have implicated Ginkgo biloba in clinically adverse bleeding disorders. Ginkgo biloba has been reported to increase pain-free walking distance among patients with peripheral artery disease (PAD). Standard PAD therapy includes 325 mg/day aspirin. The objective of this study was to examine potential adverse effects of concomitant aspirin and Ginkgo biloba on platelet function. Ginkgo biloba (EGb 761, 300 mg/day) was compared with placebo for effects on measures of platelet aggregation among adults consuming 325 mg/day aspirin in a randomized, double-blind, placebo-controlled, parallel design trial of 4-week duration...
December 2007: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://www.readbyqxmd.com/read/15939048/complementary-therapies-for-peripheral-arterial-disease-systematic-review
#3
REVIEW
Max H Pittler, Edzard Ernst
While peripheral arterial disease (PAD) affects a considerable proportion of patients in the primary care setting, there is a high level of use of complementary treatment options. The aim was to assess the effectiveness of any type of complementary therapy for peripheral arterial disease. A systematic review was performed. Literature searches were conducted on Medline, Embase, Amed, and the Cochrane Library until December 2004. Hand-searches of medical journals and bibliographies were conducted. There were no restrictions regarding the language of publication...
July 2005: Atherosclerosis
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"